Improving bowel preparation for colonoscopy in people with IBD
Official title: Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients: A National Multicenter Prospective Study
Run by Changhai Hospital · NCT07335705 · Data updated 2026-11-12
This project will test whether current bowel-prep practices and individual patient factors affect how clean the bowel is for people with IBD having a colonoscopy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Changhai Hospital Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | December 8, 2025 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT07335705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18 years and older) with a diagnosis of IBD per the 2023 guidelines who are scheduled for colonoscopy and can provide informed consent are ideal candidates.
✕Probably not a fit
Patients with recent major myocardial infarction, severe cardiac/hepatic/renal failure, active anticoagulant use or coagulation disorders, pregnancy or lactation, recent acute intestinal infection, colorectal tumors or obstruction, or severe cognitive or hearing impairment are excluded and unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patients scheduled for colonoscopy at participating hospitals will be approached before the procedure or within seven days after their colonoscopy to give informed consent and complete a detailed questionnaire. The questionnaire records patient factors (eg, BMI, surgery history, diabetes, bowel habits) and specifics of the bowel-preparation protocol (diet, cleansing agent, dose, timing, and interval before colonoscopy). Clinicians will record Boston Bowel Preparation Scale scores for each segment and collect colonoscopy diagnoses and endoscopic activity scores. Data will be used to describe current protocol implementation since the 2023 guidelines, identify risk factors for poor preparation, and develop a prediction model to guide personalized regimens.
Why it matters
Potential benefit: If successful, this work could enable personalized bowel-prep plans that produce cleaner colons, reduce repeat procedures, and improve diagnostic accuracy for people with IBD.
How similar studies have gone: Prior work in general colonoscopy populations has identified risk factors and produced prediction tools for poor bowel prep, but IBD-specific, post-2023-guideline data and validated models remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 years or older, of any gender, scheduled for colonoscopy; * Patients diagnosed with Inflammatory Bowel Disease (IBD) according to the 2023 edition of the Guidelines for the Diagnosis and Treatment of Inflammatory Bowel Disease; * Voluntary participation in this study and provision of signed informed consent. Exclusion Criteria: * History of acute myocardial infarction (within the past 6 months), severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders; * Current use of anticoagulants (e.g., aspirin, warfarin) or presence of coagulation disorders; * Pregnant or lactating women; * Acute intestinal infection within the past 2 weeks; * History of colorectal tumors, familial adenomatous polyposis, or Peutz-Jeghers syndrome; * History of intestinal obstruction, perforation, stenosis, or any other condition preventing completion of the examination; * Severe hearing impairment, cognitive dysfunction, or inability to cooperate with the survey; * Individuals already enrolled in this study who schedule a repeat colonoscopy; * Currently participating in another clinical observational trial or having participated in any other clinical trial within the past 60 days; * Refusal to sign the written informed consent form.
Where it's running
-
Changhai Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Zhao-shen Li, M.D.
- Email: zhaoshenli@hotmail.com
- Phone: 13386273620
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pre-packaged low-residue diet (Maifu Changqing®) for bowel preparation in adults with IBD
This project will see if a pre-packaged low-residue nutrition powder (Maifu Changqing®) makes bowel preparation easier and better nourishes adults with IBD who are having a colonoscopy.
-
Maternal and infant microbiome links to infant gut inflammation and pregnancy outcomes in people with IBD
This project will see if mothers' microbiomes, diets, and breastmilk are linked to infant gut inflammation (measured by fecal calprotectin) in pregnant people with and without IBD.
-
Infliximab plus the Crohn's Disease Exclusion Diet for children with Crohn's disease
This will test whether starting a Crohn's Disease Exclusion Diet at the same time as infliximab helps children with moderate-to-severe Crohn's disease get better and stay in remission.
-
SMART-IBD app for teens with inflammatory bowel disease
This will test whether the SMART-IBD smartphone app helps adolescents ages 13–17 with IBD take their medicines and manage symptoms better than completing daily diaries alone.
-
Pre-Packaged Low-Residue Diet for Bowel Prep in IBD Patients
This study tests whether a pre-packaged low-residue diet, Maifu Changqing Complete Nutritional Formula Powder, helps bowel prep for colonoscopy in people with inflammatory bowel disease.
-
Investigating bowel preparation quality before colonoscopy
This study is testing how well different bowel prep methods work for people getting a colonoscopy to see if new guidelines can help improve the process.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.